Corey Walker serves as the CEO of ILC Dover. Mr. Walker had previously worked closely with New Mountain Capital from 2016 to 2020 while he was a senior executive at Avantor, where he served as Executive Vice President of the Americas, as well as the global Biomaterials and Electronic Materials businesses. Mr. Walker brings nearly two decades of experience accelerating the growth of life sciences and advanced materials businesses.
Mr. Walker’s extensive leadership experience and demonstrated ability to build successful organizations and businesses complement ILC Dover’s accelerated growth trajectory and transformational journey. Following ILC Dover’s acquisition of Flexan in August, Mr. Walker will lead a combined company of more than 1,900 employees with significant opportunities to serve a broad client base in the biopharmaceutical, pharmaceutical and medical device end markets. In addition to Avantor, Mr. Walker has held leadership roles at DCP Midstream, Halliburton Energy Services, Dow Chemical and Dell Technology. He holds a bachelor’s in marketing and business management from Brigham Young University, and an MBA from Harvard Business School.